Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
285.8 USD | -0.17% | +3.22% | -0.74% |
Mar. 09 | Amgen Presents New Research on Otezla at AAD 2024 | CI |
Mar. 06 | Amgen Keeps Q2 Dividend at $2.25 a Share, Payable June 7 to Stockholders of Record May 17 | MT |
Financials (USD)
Sales 2024 * | 33.01B | Sales 2025 * | 34.06B | Capitalization | 153B |
---|---|---|---|---|---|
Net income 2024 * | 6.13B | Net income 2025 * | 7.57B | EV / Sales 2024 * | 6.06 x |
Net Debt 2024 * | 46.57B | Net Debt 2025 * | 40.77B | EV / Sales 2025 * | 5.7 x |
P/E ratio 2024 * |
24.8
x | P/E ratio 2025 * |
19.2
x | Employees | 26,700 |
Yield 2024 * |
3.23% | Yield 2025 * |
3.5% | Free-Float | 99.75% |
Latest transcript on Amgen Inc.
1 day | -0.17% | ||
1 week | +3.38% | ||
Current month | +4.56% | ||
1 month | +3.19% | ||
3 months | -0.74% | ||
6 months | +5.72% | ||
Current year | -0.59% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 61 | 06-05-31 |
Peter Griffith
DFI | Director of Finance/CFO | 65 | 19-10-22 |
Chief Tech/Sci/R&D Officer | 53 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Charles Holley
BRD | Director/Board Member | 67 | 17-02-02 |
Ellen Kullman
BRD | Director/Board Member | 68 | 16-10-13 |
Robert Williams
BRD | Director/Board Member | 75 | 14-10-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
7.84% | 0 M€ | 0.00% | - | |
7.63% | 0 M€ | 0.00% | - | |
5.08% | 108 M€ | +12.91% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 285.9 | -0.15% | 562 709 |
24-03-27 | 286.3 | +1.61% | 2,256,315 |
24-03-26 | 281.8 | +0.34% | 3,343,181 |
24-03-25 | 280.8 | +1.68% | 2,954,416 |
24-03-22 | 276.2 | -0.28% | 2,303,249 |
Delayed Quote Nasdaq, March 28, 2024 at 11:38 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.59% | 153B | |
+35.62% | 701B | |
+26.24% | 571B | |
+1.21% | 381B | |
+20.89% | 334B | |
+17.04% | 319B | |
+1.00% | 210B | |
+2.77% | 210B | |
-6.11% | 201B | |
-3.20% | 157B |